Rapt Therapeutics, Inc.
SEC CIK 1673772 · RAPT · last insider filing 2026-03-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gray Mary ANN | Director | filed 2019 - 2026 |
| Dombkowski Ashley L. | Director | filed 2025 - 2026 |
| Braunstein Scott | Director | filed 2025 - 2026 |
| Wong Brian Russell | Director · President and CEO | filed 2019 - 2026 |
| Lyons-Williams Lori | Director | filed 2021 - 2026 |
| Giordano Michael F | Director | filed 2019 - 2026 |
| Kozick Linda | Director | filed 2019 - 2026 |
| Robbins Wendye | Director | filed 2019 - 2025 |
| Goeddel David V | Director | filed 2019 - 2024 |
| Svennilson Peter | Director | filed 2019 - 2024 |
| Rieflin William JL | Director | filed 2019 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Young Rodney KB | Chief Financial Officer | filed 2019 - 2026 |
| Brockstedt Dirk G. | Chief Scientific Officer | filed 2019 - 2026 |
| HO William | Chief Medical Officer | filed 2019 - 2025 |
| Lam Karen C | VP, Finance and Controller | filed 2019 - 2021 |
| Hall Eric J. | Interim CFO | filed 2019 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.